LSTM Home > LSTM Research > LSTM Online Archive

How robust are malaria parasite clearance rates as indicators of drug effectiveness and resistance?

Downloads

Downloads per month over past year

Hastings, Ian ORCID: https://orcid.org/0000-0002-1332-742X, Kay, Katherine and Hodel, EvaMaria ORCID: https://orcid.org/0000-0001-5821-1685 (2015) 'How robust are malaria parasite clearance rates as indicators of drug effectiveness and resistance?'. Antimicrobial Agents and Chemotherapy, Vol 59, Issue 10, pp. 6428-6436.

[img]
Preview
Text
Antimicrob_Agent_Chemo_Acc_Manu_2015.pdf - Accepted Version

Download (958kB) | Preview

Abstract

Artemisinin combination therapies (ACTs) are currently the first line drugs for treating uncomplicated falciparum malaria, the most deadly of the human malarias. Malaria parasite clearance rates estimated from patients' blood following ACT treatment have been widely adopted as a measure of drug effectiveness and as surveillance tools for detecting the presence of potential artemisinin drug resistance. This metric has not been investigated in detail, nor have its properties or potential shortcomings been identified. Herein, the pharmacology of drug treatment, parasite biology, and human immunity are combined to investigate the dynamics of parasite clearance following ACT treatment. This approach parsimoniously recovers the principal clinical features and dynamics of clearance. Human immunity is the primary determinant of clearance rates unless, or until, artemisinin killing has fallen to near-ineffective levels. Clearance rates are therefore highly insensitive metrics for surveillance that may lead to over-confidence as even quite substantial reductions in drug sensitivity may not be detected as slower clearance rates. Equally serious is the use of clearance rates to quantify the impact of ACT regime changes as this strategy will plausibly miss even very substantial increases in drug effectiveness. In particular, the malaria community may be missing the opportunity to dramatically increase ACT effectiveness through changes in regimen, particularly through a switch to twice-daily regimens and/or increases in artemisinin dosing levels. The malaria community therefore appears over reliant on a single metric of drug effectiveness, parasite clearance rate that has significant and serious shortcomings.

Item Type: Article
Subjects: QX Parasitology > QX 20 Research (General)
WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases
WC Communicable Diseases > Tropical and Parasitic Diseases > WC 750 Malaria
WC Communicable Diseases > Tropical and Parasitic Diseases > WC 765 Prevention and control
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Biological Sciences > Department of Tropical Disease Biology
Digital Object Identifer (DOI): https://doi.org/10.1128/AAC.00481-15
Depositing User: Mary Creegan
Date Deposited: 08 Sep 2015 09:14
Last Modified: 19 Sep 2019 11:29
URI: https://archive.lstmed.ac.uk/id/eprint/5292

Statistics

View details

Actions (login required)

Edit Item Edit Item